KELES (κέλης): a race horse or fast sailing ship
€250m
AUM
€8m – €30m
ticket size
growth stage
demonstrated profitability, scaling inflection point
Shaping the future of healthcare
Discover industry trends
Stay ahead of the curve with our insights on the latest advancements in digital health, techbio, and AI
Portfolio success stories
Get updates on the achievements of our portfolio companies as they grow, scale, and disrupt the healthcare industry
Investment and market insights
Gain valuable perspectives from our team and industry experts on the evolving healthcare landscape
Press releases and announcements
Stay informed with the latest news from our firm, including new investments, partnerships, and key milestones
-
Alexandre Ziad Karkour is a strategic advisor specializing in cross-border M&A, private equity, and venture capital, with a track record in tech, financial services, and healthcare. As Venture Partner, Alex will support KELES in fundraising, building dealflow and investment decisions. Alex began his career at Reed Elsevier in Paris before joining SmithKline Beecham in London,
our vision
At the heart of our mission lies a commitment to pioneering today’s digital healthcare innovation across Europe.
Our vision is to integrate traditional healthcare methodologies with revolutionary digital solutions, thereby elevating patient care, advancing AI research and development, and transforming diagnostics.
We are uniquely positioned to access the best deals, enable scale up and maximise exit opportunities. We’ve sat at every seat around the table; from inception to exit to investor and acquirer, we know the economics and how-to of execution
our purpose
accelerating digital health growth across Europe
At the forefront of our mission is the ambition to catalyse the rapid expansion of digital health in Europe. Our purpose is to be the driving force behind this transformation, fostering an environment where digital health can thrive, innovate, and redefine the boundaries of what’s possible in healthcare.
enabling new healthcare possibilities
Our approach is holistic, focusing not just on technological innovation, but on how these technologies can be harmoniously woven into the fabric of healthcare. By harnessing the power of AI and data science, we aim to facilitate formidable progress in medical research, treatment, and patient care.
health tech innovation
We are a venture capital firm investing in European digital health and techbio companies, with a focus on R&D, diagnostics, and patient care. As healthcare faces increasing global pressure, we believe in the power of technology and science to revolutionize patient outcomes
proven track record
Our team, with experience in founding and scaling over 100 companies, supports startups through every growth phase. We target high-potential European regions where innovation thrives but funding is limited, aiming to close the gap from Series A onwards
driving healthcare transformation with technology
Leveraging technology and AI to transform healthcare, we invest in companies that align with the evolving needs of the industry, providing access to our extensive global network and driving both impact and returns
investment segments
New R&D model
technobio & digitised trials
Diagnostics
AI imaging & digital medtech
Patient care
Acute & chronic
15%
of healthcare professionals are 65+
90 m+
grey tsunami
Low
R&D Productivity
managing partners
healthcare c-suite
former chief strategy officer Sanofi
founding partner ascension life fund
exited healthcare entrepreneur